Insider Transactions in Q1 2021 at Eagle Pharmaceuticals, Inc. (EGRX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Feb 23 2021	Scott Tarriff	SELL Bona fide gift	Direct	16,340 -1.06%	-
Feb 02 2021	Brian Joseph Cahill CHIEF FINANCIAL OFFICER	BUY Grant, award, or other acquisition	Direct	8,900 +24.41%	-
Feb 02 2021	Judith Ng Cashin Chief Medical Officer	BUY Grant, award, or other acquisition	Direct	2,000 +50.0%	-
Feb 02 2021	David Pernock Pres & Chief Operating Officer	BUY Grant, award, or other acquisition	Direct	9,700 +15.08%	-
Jan 29 2021	Brian Joseph Cahill CHIEF FINANCIAL OFFICER	SELL Payment of exercise price or tax liability	Direct	637 -3.3%	$29,302 $46.67 P/Share
Jan 23 2021	Scott Tarriff	SELL Payment of exercise price or tax liability	Direct	4,631 -0.3%	$217,657 $47.7 P/Share
Jan 23 2021	David Pernock Pres & Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	1,892 -4.04%	$88,924 $47.7 P/Share
Jan 07 2021	David Pernock Pres & Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	906 -1.9%	$45,300 $50.97 P/Share
Jan 07 2021	Brian Joseph Cahill CHIEF FINANCIAL OFFICER	SELL Payment of exercise price or tax liability	Direct	237 -1.63%	$11,850 $50.97 P/Share
Jan 05 2021	Brian Joseph Cahill CHIEF FINANCIAL OFFICER	SELL Payment of exercise price or tax liability	Direct	746 -4.88%	$37,300 $50.02 P/Share
Jan 05 2021	David Pernock Pres & Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	2,088 -4.19%	$104,400 $50.02 P/Share

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Value

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

Operation

Value

Type

Receive news related to EAGLE PHARMACEUTICALS, INC.